OAKLAND, Calif.--(BUSINESS WIRE)--Omicia Inc. will launch its new ACMG-scoring module for the Opal Clinical™ interpretation and reporting software platform at the ACMG Annual Clinical Genetics Meeting in Tampa, March 8-12th. This functionality provides an intuitive interface and workflow for clinical testing labs to systematically assess the disease-causing potential of genetic variants using the evidence-based classification system defined in the 2015 Standards and Guidelines for the Interpret
For more information, please visit
http://www.businesswire.com/news/home/20[...]ring-Classification-Guidelines